A significant reduction in body weight and fat in obese individuals resulted in the down-regulation of inflammatory and hepatic markers such as C-reactive protein (CRP), glutamic pyruvic transaminase (GPT), glutamic oxaloacetic transaminase (GOT), γ-glutamyl transpeptidase (γGT), thus preventing metabolic syndrome [37]. The gene discussed is CRP; the disease is metabolic syndrome.